Clare Arnott

Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

Gemma A. Figtree, Stephen T. Vernon, Nermin Hadziosmanovic et al. · The Lancet · 2021 · 290 citations

Preventive Medicine, Cardiovascular Epidemiology, Health Policy +12

Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

Kaivan Vaidya, Clare Arnott, Gonzalo J. Martínez et al. · JACC. Cardiovascular imaging · 2017 · 284 citations

Thrombosis, Colchicine Therapy, Cardiovascular Disease +10

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Brendon L. Neuen, Hiddo J.L. Heerspink, Priya Vart et al. · Circulation · 2023 · 252 citations · Full text

Colchicine in Cardiovascular Disease: In-Depth Review.

Spyridon Deftereos, Frans Beerkens, Binita Shah et al. · PubMed · 2022 · 135 citations · Full text

Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

Jingwei Li, Bruce Neal, Vlado Perkovic et al. · Kidney International · 2020 · 126 citations · Full text